Bone Density Conservation Agents

"Bone Density Conservation Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

Descriptor ID	D050071
MeSH Number(s)	D27.505.696.242
Concept/Terms	Bone Density Conservation Agents Bone Density Conservation Agents Antiresorptive Agents Antiresorptive Agents Bone Resorption Inhibitors Inhibitors, Bone Resorption Resorption Inhibitors, Bone Bone Resorption Inhibitory Agents Antiresorptive Drugs

Below are MeSH descriptors whose meaning is more general than "Bone Density Conservation Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Bone Density Conservation Agents [D27.505.696.242]

Below are MeSH descriptors whose meaning is more specific than "Bone Density Conservation Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bone Density Conservation Agents" by people in this website by year, and whether "Bone Density Conservation Agents" was a major or minor topic of these publications.

Bar chart showing 26 publications over 12 distinct years, with a maximum of 5 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	1	1	2
2007	3	0	3
2008	1	1	2
2010	3	1	4
2011	3	1	4
2012	0	1	1
2014	4	1	5
2015	1	0	1
2016	0	1	1
2017	0	1	1
2018	1	0	1
2021	0	1	1

Below are the most recent publications written about "Bone Density Conservation Agents" by people in Profiles.

Wang YY, Su YC, Lai PC, Chou YY, Wu PT, Tsai MC, Tai TW, Wu CH, Chang YF, Tu YK, Fang CJ, Lin CJ, Kuan FC, Hsu KL, Hong CK, Su WR, Huang MT, Shih CA. Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trials. Arch Osteoporos. 2025 Mar 06; 20(1):33.

View in: PubMed
Wang B, Qian JY, Tang TT, Lin LL, Yu N, Guo HL, Ni WJ, Lv LL, Wen Y, Li ZL, Wu M, Cao JY, Liu BC. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy. Diabetes. 2021 11; 70(11):2639-2651.

View in: PubMed
Bauer C, le Saux O, Pomozi V, Aherrahrou R, Kriesen R, St?lting S, Liebers A, Kessler T, Schunkert H, Erdmann J, Aherrahrou Z. Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation. Sci Rep. 2018 04 11; 8(1):5812.

View in: PubMed
Goodwin JS. In Reply-Bisphosphonates and Osteonecrosis of the Jaw. Mayo Clin Proc. 2017 07; 92(7):1167.

View in: PubMed
Goodwin JS, Zhou J, Kuo YF, Baillargeon J. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer. Mayo Clin Proc. 2017 Jan; 92(1):106-113.

View in: PubMed
Ferguson S, Feudjo Tepie M, Taylor A, Roddam A, Critchlow C, Iqbal M, Spangler L, Bayly J. The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK: a study of patient records from the UK Clinical Practice Research Datalink. J Eval Clin Pract. 2016 Feb; 22(1):31-39.

View in: PubMed
Li L, Roddam A, Ferguson S, Feudjo-Tepie M, Taylor A, Jick S. Switch patterns of osteoporosis medication and its impact on persistence among postmenopausal women in the U.K. General Practice Research Database. Menopause. 2014 Oct; 21(10):1106-13.

View in: PubMed
Strong AL, Ohlstein JF, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA. Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms. Stem Cell Res Ther. 2014 Aug 28; 5(4):105.

View in: PubMed
Uyanne J, Calhoun CC, Le AD. Antiresorptive drug-related osteonecrosis of the jaw. Dent Clin North Am. 2014 Apr; 58(2):369-84.

View in: PubMed
Fontenot HB, Harris AL. Pharmacologic management of osteoporosis. J Obstet Gynecol Neonatal Nurs. 2014 Mar-Apr; 43(2):236-45; quiz E20-1.

View in: PubMed

People

Explore

Similar Concepts

Top Journals